DownloadsContact UsAlert ServicePrint this page
 
 

Investor Overview

Intercytex logo - link to home  

Intercytex is the leading developer of regenerative medicine products. Intercytex uses its fully integrated cell technology platform to develop living, human cell-based products that harness the innate ability of human cells to regenerate and repair the body, at commercially viable scale in attractive markets.

Intercytex commenced operations in 2000 and currently employs around 50 staff. In addition to its head office in Cambridge, UK, it has its own GMP compliant clinical production facility plus research and development laboratories in Manchester, UK and a dedicated stem cell research laboratory in Sheffield, UK. Additional laboratories are located in Boston, US..

Intercytex’ shares trade on the Alternative Investment Market of the London Stock Exchange under the ticker symbol ICX.L.

Corporate fact sheet

 
Home  · Disclaimer  ·  Privacy Statement  ·  Site Map